采用对侧倒置分支的窗式与分支式腔内动脉瘤修复术的结局
回顾性分析2010年1月至2023年9月共32例接受含倒置分支定制分叉支架的窗式与分支式腔内主动脉修复术(F/B-EVAR)患者,技术成功率87.5%,1年与2年生存率分别为92.7%±5.1%与74.3%±10.1%,无动脉瘤相关死亡;中位随访13个月,1例倒置分支闭塞,1支目标血管闭塞(0.9%),1年与2年免于总体再干预率分别为73.5%±8.0%与68.3%±9.0%。
要点
- 32例含倒置分支F/B-EVAR患者技术成功率为87.5%(28/32)。
- 1年与2年估计生存率分别为92.7%±5.1%与74.3%±10.1%,无动脉瘤相关死亡。
- 中位随访13个月,1例倒置分支闭塞,1支目标血管(右肾动脉)闭塞(0.9%)。
核心结论
- 含倒置分支的F/B-EVAR可作为处理肾动脉至分叉距离短的复杂动脉瘤的可行腔内选择,但倒置分支使用存在显著技术挑战,可能与再干预需求较高相关,应仔细确认倒置分支的正确插管。
研究设计与样本
- 回顾性分析2010年1月至2023年9月接受含倒置分支定制分叉支架的F/B-EVAR患者,共32例(26例男性;平均年龄77±6.2岁),时间-事件数据采用Kaplan-Meier法分析。
主要发现
- 技术成功28例(87.5%);2例技术失败为既往EVAR患者对侧分支误置,其中1例因3b型内漏行开放转换,1例误置对侧分支闭塞后行股-股交叉旁路。
- 另2例技术失败分别归因于源自左肾动脉和右肾动脉水平窗式装置的3c型内漏和1c型内漏。
- 1例(3.1%)术后30天内死于硬膜下出血;1年与2年估计患者生存率分别为92.7%±5.1%与74.3%±10.1%,无动脉瘤相关死亡。
- 中位随访13个月,1例(3.1%)倒置分支闭塞(另1例闭塞由对侧分支误置所致)并行股-股交叉旁路;1支目标血管(右肾动脉)闭塞(0.9%),导致永久性肾功能显著下降。
- 1年与2年免于总体再干预率分别为73.5%±8.0%与68.3%±9.0%;随访影像中另有4例(12.5%)出现3c型内漏,其中3例源自肾支架水平窗孔;倒置分支装置与主体支架间无连接问题,单密封支架倒置分支设计与3型内漏发生无显著相关性(log-rank P=.064)。
临床怎么用
- 作者认为含倒置分支的F/B-EVAR可作为处理肾动脉至分叉距离短的复杂动脉瘤的可行腔内选择,但使用倒置分支存在显著技术挑战且可能与再干预需求较高相关,应仔细确认倒置分支的正确插管。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To report technical success and evaluate clinical outcomes of fenestrated and branched endovascular aortic repair (F/B-EVAR) incorporating a contralateral inverted limb. METHODS: Patients who underwent F/B-EVAR with a custom-made bifurcated device containing an inverted limb between January 2010 and September 2023 were retrospectively analyzed. Time-to-event data were analyzed using the Kaplan-Meier method. RESULTS: A total of 32 patients (26 men; mean age 77±6.2 years) were included in the analysis. Technical success was achieved in 28 patients (87.5%). Two technical failures resulted from misplaced contralateral limbs in patients with previous endovascular aortic repair (EVAR), necessitating one open conversion due to a type 3b endoleak, and one femoro-femoral crossover bypass after occlusion of a misplaced contralateral limb. Additionally, two technical failures were attributed to a type 3c endoleak and a type 1c endoleak, originating from a fenestrated device at the level of the left and right renal artery, respectively. One patient (3.1%) died <30 days post-operatively due to a subdural hemorrhage. Estimated patient survival after 1 and 2 years was 92.7%±5.1%, and 74.3%±10.1%, respectively. No aneurysm-related deaths were observed. During the median follow-up of 13 months, one (3.1%) inverted limb occluded, in addition to the occlusion resulting from a misplaced contralateral limb, and was treated with a femoro-femoral crossover bypass. One target vessel (right renal artery) occluded (0.9%), resulting in a permanent, significantly reduced renal function. Freedom from overall reintervention after 1 and 2 years was 73.5%±8.0% and 68.3%±9.0%, respectively. An additional four patients (12.5%) presented with a type 3c endoleak during follow-up scans, three of which originated from fenestrations at the level of the renal stents. There were no junctional problems between the inverted limb device and the main endograft, and no significant correlation was found between the one-sealing-stent inverted limb device design and the onset of type 3 endoleak (log-rank P=.064). CONCLUSIONS: F/B-EVAR incorporating an inverted limb can be a viable endovascular option to manage complex aneurysms with a short renal artery to bifurcation distance. However, using the inverted limb presents a notable technical challenge and could be associated with a higher need for reintervention. Carefully confirming correct cannulation of the inverted limb is warranted.
引用
- Huistra EWM, Tielliu IFJ, de Vries JPM, et al. Outcomes of fenestrated and branched endovascular aneurysm repair with an inverted contralateral limb. J Vasc Surg. 2024. PMID: 39303861. doi:10.1016/j.jvs.2024.07.110
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。